High performance capillary electrophoresis for determination of the enantiomers of 2-arylpropionic acid derivatives in human serum: Pharmacokinetic studies of ketoprofen enantiomers following administration of standard and sustained release tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 4, 2004, Pages 807-816

  Główka, Franciszek K ^a   Karaźniewicz, Marta ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

2 Arylpropionic acid derivatives; Bioavailability; Capillary zone electrophoresis; Enantiomers' pharmacokinetics; Validation parameters

Indexed keywords

ARYLPROPIONIC ACID DERIVATIVE; BUFFER; DICHLOROMETHANE; ELECTROLYTE; FLURBIPROFEN; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; IBUPROFEN; KETOPROFEN DERIVATIVE; NAPROXEN; SILICON DIOXIDE; TRIETHANOLAMINE;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; CALIBRATION; CAPILLARY; CAPILLARY ELECTROPHORESIS; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG GLUCURONIDATION; ELECTROPHORETIC MOBILITY; ENANTIOMER; FEMALE; HUMAN; MALE; MIGRATION; PARAMETER; PH; PRIORITY JOURNAL; RACEMIC MIXTURE; SERUM; STATISTICAL ANALYSIS; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE PREPARATION;

ADULT; ANALYSIS OF VARIANCE; DELAYED-ACTION PREPARATIONS; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; KETOPROFEN; MALE; MIDDLE AGED; PROPIONIC ACIDS; STEREOISOMERISM; TABLETS;

EID: 2942581056     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.01.030     Document Type: Article

References (20)

1. Hutt A.J., Caldwell J. J. Pharm. Pharmacol. 35:1983;693-704
2. Baek S.J., Wilson L.C., Lee C.H., Eling T.E. J. Pharmacol. Exp. Ther. 301(3):2002;1126-1131
3. Blanco M., Coello J., Iturriaga H., Maspoch S., Perez-Maseda C. J. Chromatogr. A. 793:1998;165-175
4. Fanali S., Aturki Z. J. Chromatogr. A. 694:1995;297-305
5. Lelievre F., Gareil P. J. Chromatogr. A. 735:1996;311-320
6. Glówka F.K. J. Pharm. Biomed. Anal. 30:2002;1035-1045
7. M.M. Rogan, K.D. Altria, Introduction to the Theory and Applications of Chiral Capillary Electrophoresis, Beckman Instruments, Fullerton, CA, 1993.
8. D. Heiger, High Performance Capillary Electrophoresis, Agilent Technologies, Germany, 2000, pp. 17-43, 84.
9. A. Boobis, M. Rawlins, S. Thomas, M. Wilkins, in: C. Dollery (Ed.), The Drugs, Churchill Livingstone, Edinburgh, 1999, p. 18.
10. Pehourcq F., Lagrange F., Labat L., Bannwarth B. J. Liq. Chromatogr. 18:1995;3969-3979
11. Yagi M., Shibukawa A., Nakagawa T. Chem. Pharm. Bull. 38:1990;2513-2517
12. Glówka F.K. Chem. Anal. (Warsaw). 43:1998;79-84
13. Whelk O1, Merck Instruction, Germany, 1995.
14. DeFrancesco L. Chemist 2002;11:59-64 (available at http://pubs.acs.org/ subscribe/journals/tcaw).
15. A.C. Moffat, J.V. Jackson, M.S. Moss, B. Widdep, Clarkes Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post-Mortem Material, Pharmaceutical Press, London, 1986, pp. 630-680.
16. Shah V.P., Midha K.K., Dighe S., McGilveray I., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309-312
17. Hermann T.W., Glówka F.K., Garrett E.R. J. Pharm. Sci. 82:1993;1102-1111
18. Lagrange F., Pehourcq F., Matoga M., Bannworth B. J. Pharm. Biomed. Anal. 23:2000;793-802
19. Lin J.H., Cocchetto D.M., Duggan D.E. Clin. Pharmacokinet. 12:1987;402-432
20. Rudy A.C., Liu Y., Brater C., Hall S.D. J. Clin. Pharmacol. 38:1998;3-10